Advertisement

Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study

  • Richard D. SembaEmail author
  • Stefania Bandinelli
  • Kai Sun
  • Jack M. Guralnik
  • Luigi Ferrucci
Short Communication

Abstract

Advanced glycation end products (AGEs) are bioactive molecules found in foods and generated endogenously in the body. AGEs induce cross-linking of collagen and increase the stiffness of skeletal muscle and cartilage. We characterized the relationship between a plasma AGE, carboxymethyl-lysine (CML), and slow walking speed (lowest quintile of walking speed) in older adults. Walking speed over a 4 m course was assessed in 944 adults, aged ≥65 years, in the InCHIANTI study, a population-based study of aging and mobility disability conducted in two towns in Tuscany, Italy. Participants in the highest quartile of plasma CML were at higher risk of slow walking speed (Odds Ratio [O.R.] 1.56, 95% Confidence Interval [C.I.] 1.02–2.38, P = 0.04) compared to those in the lower three quartiles of plasma CML in a logistic regression models adjusting for age, education, cognitive function, smoking, and chronic diseases. After exclusion of participants with diabetes, participants in the highest quartile of plasma CML were at higher risk of slow walking speed (O.R. 1.87, 95% C.I. 1.15–3.04, P = 0.01) adjusting for the same covariates. In older community-dwelling adults, elevated plasma CML is independently associated with slow walking speed.

Keywords

Advanced glycation end products Aging Carboxymethyl-lysine Physical performance Walking speed 

Notes

Acknowledgments

This work was supported by National Institute on Aging Grant R01 AG027012, R56 AG027012, R01 AG029148 and the Intramural Research Program, National Institute on Aging, NIH.

References

  1. Bandinelli S, Pozzi M, Lauretani F, Phillips C, Shumway-Cook A, Guralnik JM, Ferrucci L (2006) Adding challenge to performance-based tests of walking: The Walking InCHIANTI Toolkit (WIT). Am J Phys Med Rehabil 85:986–991CrossRefPubMedGoogle Scholar
  2. Basta G, Schmidt AM, de Caterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582–592CrossRefPubMedGoogle Scholar
  3. Boehm BO, Schilling S, Rosinger S, Lang GE, Lang GK, Kietsch-Engel R, Stahl P (2004) Elevated serum levels of Nε-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia 47:1376–1379CrossRefPubMedGoogle Scholar
  4. Bohlender JM, Franke S, Stein G, Wolf G (2005) Advanced glycation end products and the kidney. Am J Renal Physiol 289:F645–F659CrossRefGoogle Scholar
  5. Dalal M, Ferrucci L, Sun K, Beck J, Fried LP, Semba RD (2009) Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci 64:132–137PubMedGoogle Scholar
  6. De la Maza MP, Uribarri J, Olivares D, Hirsch S, Leiva L, Barrera G, Bunout D (2008) Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury. Rejuvenation Res 11:1041–1048CrossRefPubMedGoogle Scholar
  7. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, Guralnik JM (2000) Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48:1618–1625PubMedGoogle Scholar
  8. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMedGoogle Scholar
  9. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BW, Uribarri J, Vlassara H (2004) Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 104:1287–1291CrossRefPubMedGoogle Scholar
  10. Guralnik JM, Fried LP, Simonsick EM, Kasper D, Lafferty ME (1995) The Women’s Health and Aging Study: health and social characteristics of older women with disability. National Institute on Aging, Bethesda, MD. NIH Publication No. 95-4009Google Scholar
  11. Haus JM, Carrithers JA, Trappe SW, Trappe TA (2007) Collagen, cross-linking and advanced glycation endproducts in aging human skeletal muscle. J Appl Physiol 103:2068–2076CrossRefPubMedGoogle Scholar
  12. Hernandez CJ, Tang SY, Baumbach BM, Hwu PB, Sakkee AN, van der Ham F, DeGroot J, Bank RA, Keaveny TM (2005) Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 37:825–832CrossRefPubMedGoogle Scholar
  13. James PT, Leach R, Kalamara E, Shayeghi M (2001) The worldwide obesity epidemic. Obes Res 9(Suppl 4):228S–233SCrossRefPubMedGoogle Scholar
  14. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860PubMedGoogle Scholar
  15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461–470PubMedGoogle Scholar
  16. Negrean M, Stirban A, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D (2007) Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85:1236–1243PubMedGoogle Scholar
  17. Payne GW (2006) Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation 13:343–352CrossRefPubMedGoogle Scholar
  18. Reddy GK (2004) Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit Achilles tendon. Exp Diab Res 5:143–153CrossRefGoogle Scholar
  19. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW (1995) N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34:10872–10878CrossRefPubMedGoogle Scholar
  20. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, Ferrucci L (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102:919–925CrossRefPubMedGoogle Scholar
  21. Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CDA (2005) Advanced glycation end products are associated with pulse pressure in type 1 diabetes. The EURODIAB prospective complications study. Hypertension 46:232–237CrossRefPubMedGoogle Scholar
  22. Semba RD, Najjar SS, Sun K, Lakatta EG, Ferrucci L (2009a) Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens 22:74–79CrossRefPubMedGoogle Scholar
  23. Semba RD, Ferrucci L, Sun K, Beck J, Dalal M, Varadhan R, Walston J, Guralnik JM, Fried LP (2009b) Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women. Aging Clin Exp Res 21:183–190Google Scholar
  24. Snow LM, Fugere NA, Thompson LV (2007) Advanced glycation end-product accumulation and associated protein modification in type II skeletal muscle with aging. J Gerontol A Biol Sci Med Sci 62:1204–1210PubMedGoogle Scholar
  25. Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40:1144–1151CrossRefPubMedGoogle Scholar
  26. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 72:427–433Google Scholar
  27. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28:195–201CrossRefPubMedGoogle Scholar
  28. Verzijl N, deGroot J, Oldehinkel E, Bank RA, Thorpe SR, Baynes JW, Bayliss MT, Bijlsma JWJ, Lafeber FPJG, teKoppele JM (2000) Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 350:381–387CrossRefPubMedGoogle Scholar
  29. Verzijl N, deGroot J, Ben Zaken C, Braun-Benjamin O, Maroudas A, Bank RA, Mizrahi J, Schalkwijk CG, Thorpe SR, Baynes JW, Bijlsma WJW, Lafeber FPJG, teKoppele JM (2002) Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 46:114–123CrossRefPubMedGoogle Scholar
  30. Zhang X, Frischmann M, Kientsch-Engel R, Steinmann K, Stopper H, Niwa T, Pischetsrieder M (2005) Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med 43:503–511CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Richard D. Semba
    • 1
    Email author
  • Stefania Bandinelli
    • 2
  • Kai Sun
    • 1
  • Jack M. Guralnik
    • 3
  • Luigi Ferrucci
    • 4
  1. 1.Department of OphthalmologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Azienda Sanitaria FirenzeFlorenceItaly
  3. 3.Laboratory of Epidemiology, Demography, and BiometryNational Institute on AgingBethesdaUSA
  4. 4.Longitudinal Studies Section, Clinical Research BranchNational Institute on AgingBaltimoreUSA

Personalised recommendations